⌕
Bicara Therapeutics · BCAX · Nasdaq
Tenet 61 · Solid
Compare
$9.75−2.69%At closeTenet 61 · Solid
$9.75−0.27 (−2.69%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Bicara Therapeutics (BCAX) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsHow we compute thisNot investment advice
No institutional 13F summary in the feed.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Sep 8, 2026Cohlhepp RyanPresident, COO & Interim CEOAcquired · Option exercise17,500$3.79↗
Sep 8, 2026Cohlhepp RyanPresident, COO & Interim CEODisposed · Open-market sale14,058$22.77↗
Sep 8, 2026Cohlhepp RyanPresident, COO & Interim CEODisposed · Open-market sale3,442$23.43↗
Sep 8, 2026Cohlhepp RyanPresident, COO & Interim CEODisposed · Option exercise17,500Stock Option (Right to Buy)—↗
Aug 12, 2026Larson JenniferChief Financial OfficerAcquired · Grant / award285,000Stock Option (Right to Buy)—↗
Aug 10, 2026Hyep IvanChief Financial OfficerAcquired · Option exercise12,500$3.79↗
Aug 10, 2026Hyep IvanChief Financial OfficerDisposed · Open-market sale12,500$27.97↗
Aug 10, 2026Hyep IvanChief Financial OfficerDisposed · Option exercise12,500Stock Option (Right to Buy)—↗
Aug 10, 2026Mazumdar ClaireChief Executive OfficerAcquired · Option exercise10,000$3.79↗
Aug 10, 2026Mazumdar ClaireChief Executive OfficerDisposed · Open-market sale10,000$27.98↗
Aug 10, 2026Mazumdar ClaireChief Executive OfficerDisposed · Option exercise10,000Stock Option (Right to Buy)—↗
Aug 10, 2026Cohlhepp RyanPresident and COOAcquired · Option exercise18,750$3.79↗
Aug 10, 2026Cohlhepp RyanPresident and COODisposed · Open-market sale18,750$27.98↗
Aug 10, 2026Cohlhepp RyanPresident and COODisposed · Option exercise18,750Stock Option (Right to Buy)—↗
Jul 28, 2026Bender JeremydirectorAcquired · Grant / award38,950Stock Option (Right to Buy)—↗
Jul 28, 2026Oliger Christy J.directorAcquired · Grant / award38,950Stock Option (Right to Buy)—↗
Jul 10, 2026Mazumdar ClaireChief Executive OfficerAcquired · Option exercise10,000$3.79↗
Jul 10, 2026Mazumdar ClaireChief Executive OfficerDisposed · Open-market sale9,972$28.42↗
Jul 10, 2026Mazumdar ClaireChief Executive OfficerDisposed · Open-market sale28$29.68↗
Jul 10, 2026Mazumdar ClaireChief Executive OfficerDisposed · Option exercise10,000Stock Option (Right to Buy)—↗

13F holdings are reported quarterly; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.